Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273048 · ClinicalTrials.gov registry record · NA
The MOM TO BE Study
A NA study, sponsored by Arkansas Children's Hospital Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04273048: Clinical Trial NA study, sponsored by Arkansas Children's Hospital Research Institute.
NCT04273048 is a NA study that was terminated before completion, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04273048, a NA study, was terminated before completion, sponsored by Arkansas Children's Hospital Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This research study is about the effects of diet and exercise in women undergoing fertility treatment.
Primary Outcome
Oocyte gene expression
Interventions
- OTHER Diet Intervention - Group 1
- OTHER Exercise Intervention - Group 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-06-21 |
| Phase | NA |
Why NCT04273048 stopped before completion
NCT04273048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Diet Intervention - Group 1 is the first listed.
NCT04273048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04273048 about?
NCT04273048 is a clinical study titled "The MOM TO BE Study". This research study is about the effects of diet and exercise in women undergoing fertility treatment.
What is the current status of trial NCT04273048?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-07-21. Estimated completion is 2022-06-21.
What interventions are being tested in trial NCT04273048?
The interventions under investigation include: Diet Intervention - Group 1 (OTHER), Exercise Intervention - Group 1 (OTHER).
Who is sponsoring clinical trial NCT04273048?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04273048's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy